Pieris Pharmaceuticals Inc.
July 24, 2024 - by Joey Ramson
$PIRS is leading the Prism MarketView Pharmaceuticals index after they agreed to an all-stock merger agreement with Palvella Therapeutics, a privately held clinical-stage biotech company.
